Hasil Pencarian - Simona Borstnar

  • Menampilkan 1 - 18 hasil dari 18
Perbaiki Hasil
  1. 1
    Slabost in bruhanje pri bolnikih na sistemskem zdravljenju raka

    Slabost in bruhanje pri bolnikih na sistemskem zdravljenju raka oleh Simona Borštnar

    Diterbitkan 2009-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Mesto bisfosfonatov pri zdravljenju bolnikov z rakom

    Mesto bisfosfonatov pri zdravljenju bolnikov z rakom oleh Simona Borštnar

    Diterbitkan 2008-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Priporočila za uporabo dejavnikov rasti granulocitne vrste pri bolnikih z rakom na sistemskem zdravljenju

    Priporočila za uporabo dejavnikov rasti granulocitne vrste pri bolnikih z rakom na sistemskem zdravljenju oleh Simona Borštnar, Tanja Južnič Šetina

    Diterbitkan 2009-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Pomen tumorskih označevalcev pri bolnikih s solidnimi tumorji in limfomi

    Pomen tumorskih označevalcev pri bolnikih s solidnimi tumorji in limfomi oleh Simona Borštnar, Tanja Ovčariček, Branko Zakotnik

    Diterbitkan 2010-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Intratekalna aplikacija trastuzumaba in rituksimaba

    Intratekalna aplikacija trastuzumaba in rituksimaba oleh Samo Rožman, Simona Borštnar, Barbara Jezeršek Novaković

    Diterbitkan 2011-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Preprečevanje, prepoznavanje in zdravljenje ekstravazacije citostatikov

    Preprečevanje, prepoznavanje in zdravljenje ekstravazacije citostatikov oleh Marjana Bernot, Marijana Fortuna Lužar, Simona Borštnar

    Diterbitkan 2011-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer

    Complete response in the axilla and the non-triple negative subtype are favourable prognostic factors for survival outcomes in inflammatory breast cancer oleh Cvetka Grašič Kuhar, Simona Borštnar, Barbara Gazić, Erika Matos

    Diterbitkan 2023-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Razvoj novih sistemskih zdravljenj pri bolnikih z razsejanim rakom prostate

    Razvoj novih sistemskih zdravljenj pri bolnikih z razsejanim rakom prostate oleh Boštjan Šeruga, Tomaž Milanez, Simona Borštnar, Nataša Snoj Šarvari, Breda Škrbinc

    Diterbitkan 2011-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Cannabinoids and triple-negative breast cancer treatment

    Cannabinoids and triple-negative breast cancer treatment oleh Luka Dobovišek, Simona Borštnar, Nataša Debeljak, Simona Kranjc Brezar, Simona Kranjc Brezar

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Effect of combining CBD with standard breast cancer therapeutics

    Effect of combining CBD with standard breast cancer therapeutics oleh Luka Dobovišek, Metka Novak, Fran Krstanović, Simona Borštnar, Tamara Lah Turnšek, Nataša Debeljak

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients—a single institution experience

    Axillary ultrasound for predicting response to neoadjuvant treatment in breast cancer patients—a single institution experience oleh Nina Pislar, Gorana Gasljevic, Maja Marolt Music, Simona Borstnar, Janez Zgajnar, Andraz Perhavec

    Diterbitkan 2023-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Concurrent treatment with tamoxifen and CYP2D6 inibitors: clinical significance of drug interactions

    Concurrent treatment with tamoxifen and CYP2D6 inibitors: clinical significance of drug interactions oleh Boštjan Šeruga, Brigita Novak Šarotar, Lea Knez, Simona Borštnar, Rado Janša, Marga Kocmur, Tanja Čufer

    Diterbitkan 2012-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Priporočila za zdravljenje bolnic s hormonsko odvisnim in HER 2-pozitivnim rakom dojk

    Priporočila za zdravljenje bolnic s hormonsko odvisnim in HER 2-pozitivnim rakom dojk oleh Simona Borštnar, Cvetka Grašič-Kuhar, Erika Matos, Erik Škof, Nina Čas-Sikošek, Jožica Červek, Tanja Čufer

    Diterbitkan 2010-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Efficacy and safety of selective cyclin-dependent kinases 4/6 inhibitors in hormone-receptor-positive, HER2-negative advanced breast cancer – results from a real-world setting

    Efficacy and safety of selective cyclin-dependent kinases 4/6 inhibitors in hormone-receptor-positive, HER2-negative advanced breast cancer – results from a real-world setting oleh ANJA KOVAČ, Erika Matos, Cvetka Grašič Kuhar, Marina Čakš, Tanja Ovčariček, Marina Mencinger, Mojca Humar, Simona Borštnar

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    The role of the urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in breast cancer

    The role of the urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in breast cancer oleh Iztok Takač, Tanja Čufer, Borut Gorišek, Nina Čas Sikošek, Robert Bali, Damijana Bosilj, Simona Borštnar, Maja Lampelj, Maja Ravnik, Rajko Kavalar, Nina Fokter, Darja Arko

    Diterbitkan 2011-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    Recommendations for diagnosis and treatment of patients with breast cancer (part 2)

    Recommendations for diagnosis and treatment of patients with breast cancer (part 2) oleh Simona Borštnar, Andraž Perhavec, Barbara Gazić, Barbara Vidergar – Kralj, Erika Matos, Ivica Ratoša, Janez Žgajnar, Kristijana Hertl, Marko Hočevar, Mateja Krajc, Nikola Bešič, Snežna Paulin Košir, Tanja Marinko, Ulrika Klopčič

    Diterbitkan 2019-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Factors associated with a high level of unmet needs and their prevalence in the breast cancer survivors 1–5 years after post local treatment and (neo)adjuvant chemotherapy during the COVID-19: A cross-sectional study

    Factors associated with a high level of unmet needs and their prevalence in the breast cancer survivors 1–5 years after post local treatment and (neo)adjuvant chemotherapy during t... oleh Špela Miroševič, Judith Prins, Simona Borštnar, Nikola Besić, Vesna Homar, Polona Selič-Zupančič, Polona Selič-Zupančič, Polona Selič-Zupančič, Andreja Cirila Škufca Smrdel, Zalika Klemenc-Ketiš, Zalika Klemenc-Ketiš, Zalika Klemenc-Ketiš

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy

    Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy oleh Ann H. Partridge, Samuel M. Niman, Monica Ruggeri, Fedro A. Peccatori, Hatem A. Azim, Jr., Marco Colleoni, Cristina Saura, Chikako Shimizu, Anna Barbro Sætersdal, Judith R. Kroep, Audrey Mailliez, Ellen Warner, Virginia F. Borges, Frédéric Amant, Andrea Gombos, Akemi Kataoka, Christine Rousset-Jablonski, Simona Borstnar, Junko Takei, Jeong Eon Lee, Janice M. Walshe, Manuel Ruíz Borrego, Halle CF. Moore, Christobel Saunders, Fatima Cardoso, Snezana Susnjar, Vesna Bjelic-Radisic, Karen L. Smith, Martine Piccart, Larissa A. Korde, Aron Goldhirsch, Richard D. Gelber, Olivia Pagani

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: